Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period

被引:0
作者
Zou, Qi [1 ]
Jiang, Cheng [1 ]
Lin, Pengyang [1 ]
Yu, Yangyang [1 ]
Li, Jiazheng [1 ]
Zhao, Feng [1 ]
Hu, Hao [1 ]
Sun, Shougang [1 ]
机构
[1] Lanzhou Univ, Dept Cardiol, Hosp 2, Lanzhou, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2024年 / 11卷
关键词
left atrial appendage closure; procedural-related complications; device-related thrombus; management strategy; atrial fibrillation; ORAL ANTICOAGULANTS; CATHETER ABLATION; DEVICE; FIBRILLATION; OCCLUSION; OUTCOMES; PROTECTION; THROMBUS;
D O I
10.3389/fcvm.2024.1388024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Percutaneous left atrial appendage closure (LAAC) serves as an alternative prophylactic strategy for patients with non-valvular atrial fibrillation (AF) who cannot undergo anti-coagulation therapy. Proper management of associated complications is crucial to enhancing the procedure's success rate and mitigating perioperative risks and adverse events during follow-up.Aims This study aims to summarize our center's experience and strategies in managing procedural-related complications encountered in 512 cases of LAAC with or without ablation for AF conducted from January 2020 to December 2023.Results We identified 11 significant intervention-requiring complications associated with LAAC with or without Ablation procedure. These included three cases of intraoperative thrombosis, three instances of pericardial effusion or tamponade, one case of device-related thrombosis, one peri-device leak, one systemic embolism, one bleeding episode, and one additional device-related complication. The categorization of intraoperative thrombosis was as follows: one patient exhibited heparin resistance; one experienced thrombosis due to prolonged device implantation during the LAAC with ablation procedure; and one had unexplained intraoperative thrombosis. The pericardial effusion or tamponade likely resulted from damage to the atrial appendage during LAAC device insertion. Two patients encountered device-related thrombosis and systemic embolism events possibly caused by non-standard postoperative antithrombotic medication use; one patient's peri-device leak may have resulted from incomplete endothelialization of the occluder post-surgery; one patient experienced postoperative bladder bleeding; and one patient's device-related complications occurred due to a dislodged strut frame that damaged the left atrial appendage, leading to pericardial effusion. Our proactive interventions enabled all patients with these surgical-related complications to be safely discharged, with subsequent follow-ups showing no adverse events.Conclusion Implementing targeted interventions for immediate procedural-related complications during the LAAC with or without ablation procedures enhances procedural success rates, diminishes postoperative mortality and patient disability, and bolsters stroke prevention efforts. This approach underscores the importance of a strategic response to complications, affirming the procedure's viability and safety in managing non-valvular AF in patients contraindicated for anticoagulation.
引用
收藏
页数:17
相关论文
共 42 条
  • [1] Temporal Changes and Clinical Implications of Delayed Peridevice Leak Following Left Atrial Appendage Closure
    Afzal, Muhammad R.
    Gabriels, James K.
    Jackson, Gregory G.
    Chen, Lu
    Buck, Benjamin
    Campbell, Sandra
    Sabin, Dawn F.
    Goldner, Bruce
    Ismail, Haisam
    Liu, Christopher F.
    Patel, Apoor
    Beldner, Stuart
    Daoud, Emile G.
    Hummel, John D.
    Ellis, Christopher R.
    [J]. JACC-CLINICAL ELECTROPHYSIOLOGY, 2022, 8 (01) : 15 - 25
  • [2] Late device-related thrombus associated with occult malignancy years after left atrial appendage closure
    Armouti, Ahmad O.
    Amin, Sheyar
    Rose, David Z.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (05)
  • [3] Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center
    Bai, Yuan
    Xue, Xin
    Duenninger, Erich
    Muenzel, Manuela
    Jiang, Lisheng
    Keil, Thorsten
    Fazakas, Adam
    Yu, Jiangtao
    [J]. HEART AND VESSELS, 2019, 34 (08) : 1360 - 1369
  • [5] Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation
    Black-Maier, Eric
    Piccini, Jonathan P.
    Granger, Christopher B.
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2019, 30 (12) : 2968 - 2976
  • [6] Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage
    Boersma, Lucas V.
    Ince, Hueseyin
    Kische, Stephan
    Pokushalov, Evgeny
    Schmitz, Thomas
    Schmidt, Boris
    Gori, Tommaso
    Meincke, Felix
    Protopopov, Alexey Vladimir
    Betts, Timothy
    Mazzone, Patrizio
    Foley, David
    Grygier, Marek
    Sievert, Horst
    De Potter, Tom
    Vireca, Elisa
    Stein, Kenneth
    Bergmann, Martin W.
    Al Nooryani, Arif
    Meincke, Felix
    Fiedler, Thomas
    Senatore, Gaetano
    Foley, David
    Schmidt, Boris
    Brigadeau, Francois
    Defaye, Pascal
    Teiger, Emmanuel
    Bonnet, Jean-Louis
    Wald, Christof
    Schmitz, Thomas
    Szili-Torok, Tamas
    Tschishow, Wladimir
    Mazzone, Patrizio
    Crossland, David
    Bergmann, Martin W.
    Vahanian, Alec
    Cruz-Gonzalez, Ignacio
    Thambo, Jean-Benoit
    Gori, Tommaso
    Betts, Timothy
    Al Smadi, Faisal
    Mudra, Harald
    Molitoris, Robin
    Folkeringa, Richard
    Stevenhagen, Yorick
    Gras, Daniel
    De Potter, Tom
    Tamburino, Corrado
    Molon, Giulio
    Protopopov, Vladimir
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (04)
  • [7] Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias
    Bohnen, Marius
    Stevenson, William G.
    Tedrow, Usha B.
    Michaud, Gregory F.
    John, Roy M.
    Epstein, Laurence M.
    Albert, Christine M.
    Koplan, Bruce A.
    [J]. HEART RHYTHM, 2011, 8 (11) : 1661 - 1666
  • [8] Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]
  • [9] Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis
    Cheng, Xiaocheng
    Hu, Qiongwen
    Gao, Lei
    Liu, Jian
    Qin, Shu
    Zhang, Dongying
    [J]. EUROPACE, 2019, 21 (10): : 1509 - 1518
  • [10] Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure ADRIFT a Randomized Pilot Study
    Duthoit, Guillaume
    Silvain, Johanne
    Marijon, Eloi
    Ducrocq, Gregory
    Lepillier, Antoine
    Frere, Corinne
    Dimby, Solohaja-Faniaha
    Popovic, Batric
    Lellouche, Nicolas
    Martin-Toutain, Isabelle
    Spaulding, Christian
    Brochet, Eric
    Attias, David
    Mansourati, Jacques
    Lorgis, Luc
    Klug, Didier
    Zannad, Noura
    Hauguel-Moreau, Marie
    Braik, Nassim
    Deltour, Sandrine
    Ceccaldi, Alexandre
    Wang, Hui
    Hammoudi, Nadjib
    Brugier, Delphine
    Vicaut, Eric
    Juliard, Jean-Michel
    Montalescot, Gilles
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (07)